Compare · SBTX vs UNVR
SBTX vs UNVR
Side-by-side comparison of Silverback Therapeutics Inc. (SBTX) and Univar Solutions Inc. (UNVR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SBTX and UNVR operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- UNVR is the larger of the two at $4.54B, about 28.5x SBTX ($159.2M).
- UNVR has more recent analyst coverage (9 ratings vs 6 for SBTX).
- Company
- Silverback Therapeutics Inc.
- Univar Solutions Inc.
- Price
- $5.84+0.69%
- $36.15+0.50%
- Market cap
- $159.2M
- $4.54B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2015
- News (4w)
- 0
- 0
- Recent ratings
- 6
- 9
Silverback Therapeutics Inc.
Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Its lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. The company also focuses on developing SBT6290, a product candidate that is in preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple negative breast, head and neck, and non-small cell lung cancers. In addition, it engages in developing SBT8230, a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is under development for the treatment of chronic hepatitis B virus infection; and agents that localize therapies to modulate pathways in additional oncology and fibrosis indications using TLR8 and other linker-payloads. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Univar Solutions Inc.
Univar Solutions Inc. distributes commodity and specialty chemical products, and related services worldwide. It also provides epoxy resins, polyurethanes, titanium dioxide, fumed silica, esters, plasticizers, silicones, and specialty amines; chemicals and service to midstream pipeline and downstream refinery operators; and commodity and specialty products for meat processing, baked goods, dairy, grain mill products, processed foods, carbonated soft drinks, fruit drinks, and alcoholic beverage markets. In addition, the company offers chemical products for use at various stages of production, from sap stain prevention to pulp and paper manufacturing; ingredients for cleaners, detergents, and disinfectant products; base stocks and performance-enhancing additives for lubricants and metalworking fluids; excipients, solvents, reactants, active pharmaceutical ingredients, and intermediates to pharmaceutical ingredient producers; and chemistries and products used to sanitize, balance, and supplement municipal and industrial water. Further, it provides transportation and warehousing services, chemicals and hazardous materials handling, waste management services, inventory management, and blending and repackaging services. Univar Solutions Inc. distributes its products through warehouse and direct-to-consumer delivery channels. The company was formerly known as Univar Inc. and changed its name to Univar Solutions Inc. in September 2019. The company was founded in 1924 and is headquartered in Downers Grove, Illinois.
Latest SBTX
- SEC Form SC 13G/A filed by Silverback Therapeutics Inc. (Amendment)
- Lowenthal Richard E gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 20% to 4,126,822 units (SEC Form 4)
- SEC Form 4 filed by Karas Eric
- Tanimoto Sarina gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 24% to 3,276,854 units (SEC Form 4)
- SEC Form 4 filed by Dorsey Brian
- SEC Form 4 filed by Chakma Justin
- SEC Form 4 filed by Scott Kathleen D.
- SEC Form 4 filed by Fitzpatrick Alexander A
- SEC Form 10-Q filed by Silverback Therapeutics Inc.
- Silverback Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest UNVR
- QXO Proposes Full Slate of Independent Directors for Election at Beacon Roofing Supply's 2025 Annual Meeting
- SEC Form SC 13G/A filed by Univar Solutions Inc. (Amendment)
- SEC Form 15-12G filed by Univar Solutions Inc.
- Univar Solutions And Kalsec Strengthen Partnership In Europe With Expanded Agreement For A Wide Range Of Food Ingredient Solutions
- Univar Solutions and Kalsec® Inc. Strengthen Partnership in Europe with Expanded Agreement for a Wide Range of Food Ingredient Solutions
- SEC Form 4: Buckup Jorge C. returned $1,032,227 worth of shares to the company (28,554 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Holcomb James B returned $965,964 worth of shares to the company (26,721 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Jerding Pat returned $1,253,610 worth of shares to the company (34,678 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Mcintyre Jennifer returned $3,019,899 worth of shares to the company (83,538 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Braca Joan A. returned $339,738 worth of shares to the company (9,398 units at $36.15), closing all direct ownership in the company